Metraipolis › archive › dc_dee97c774d42

Prognostic utility of immune biomarkers for identifying individuals at risk of unfavourable treatment outcomes in pulmonary tuberculosis — Europe PMC PMID:42898291

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42898291
DOI
10.3389/fimmu.2026.1928573
License (as archived)
solo-consultazione
Archived
2026-11-01T09:03:10.225Z
SHA-256 of the archived text
6512acd84cd0fd24dc600c48201353c1962791c016216fb598301d3dfbadb381
Stable URL of this page
https://metraipolis.com/documento/dc_dee97c774d42

How to cite

Prognostic utility of immune biomarkers for identifying individuals at risk of unfavourable treatment outcomes in pulmonary tuberculosis — Europe PMC PMID:42898291 — Europe PMC (en), https://europepmc.org/article/MED/42898291 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_dee97c774d42 (Metraipolis archive dc_dee97c774d42, sha256 6512acd84cd0fd24dc600c48201353c1962791c016216fb598301d3dfbadb381)
BibTeX
@misc{dcdee97c774d42,
  title = {Prognostic utility of immune biomarkers for identifying individuals at risk of unfavourable treatment outcomes in pulmonary tuberculosis — Europe PMC PMID:42898291},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42898291},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_dee97c774d42; sha256 6512acd84cd0fd24dc600c48201353c1962791c016216fb598301d3dfbadb381},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42898291. Agents can read the archived copy with the MCP tool read_document.